L. Escaut

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 293 citations · Full text

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 153 citations

Community-acquired Pneumonia, Critical Care Medicine, Antibiotics +7

Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria

Cécile Emeraud, L. Escaut, Athénaïs Boucly et al. · Antimicrobial Agents and Chemotherapy · 2019 · 125 citations · Full text

Vascular complications associated with use of HIV protease inhibitors

Daniel Vittecoq, L. Escaut, Monsuez Jj · The Lancet · 1998 · 108 citations · Full text

Thrombosis, Vascular Disease, Cardiovascular Disease +6

Urolithiasis in HIV-Positive Patients Treated with Atazanavir

C. Couzigou, Michel Daudon, J.‐L. Meynard et al. · Clinical Infectious Diseases · 2007 · 97 citations · Full text

Protease Inhibitors, Urological Research, Urology +10